Subscribe to MDT Magazine News

Tuning graphene film so it sheds water

February 2, 2011 7:37 pm | by I-Micronews | Comments

Windshields that shed water so effectively that they don?t need wipers. Ship hulls so slippery that they glide through the water more efficiently than ordinary hulls.

Edwards 4Q profit rises on heart valve sales

February 2, 2011 4:45 pm | by The Associated Press | Comments

Heart valve maker Edwards Lifesciences Corp. said Wednesday its fourth-quarter profit grew 36 percent as sales improved.Edwards said its profit rose to $64.8 million, or 54 cents per share, from $47.6 million, or 40 cents per share in the year-ago quarter. Excluding one-time charges the company...

Affymetrix 4Q profit climbs as costs shrink

February 2, 2011 1:45 pm | by The Associated Press | Comments

Genetic testing instrument maker Affymetrix Inc. said Wednesday its profit rose 42 percent in the fourth quarter as its costs decreased, offsetting lower revenue.Affymetrix said its net income grew to $4 million, or 6 cents per share. In the fourth quarter of 2009 it reported a profit of $2.8...


Brower Piven Announces Class Action Lawsuit in Connection With the Possible Acquisition of Tenet Healthcare Corporation by Community Health Services, Inc.

February 2, 2011 12:45 pm | by The Associated Press | Comments

Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the County Court, Dallas County, Texas, on behalf of all shareholders of Tenet Healthcare Corporation ("Tenet") (NYSE: THC).The claims asserted in the complaint arise from a possible buyout...

Lampreys give clues to evolution of immune system

February 2, 2011 12:39 pm | by EurekAlert | Comments

(Emory University) Biologists have discovered that primitive, predatory lampreys have structures within their gills that play the same role as the thymus, the organ where immune cells called T cells develop in mammals, birds and fish. The finding suggests that in vertebrate...


Effective Treatment of Lyme Disease-Related Arthritis Depends on Proper Diagnosis

February 2, 2011 11:33 am | by Bio-Medicine.Org | Comments

ROSEMONT, Ill., Feb. 2, 2011 /PRNewswire-USNewswire/ -- Early, correct diagnosis is the best way to prevent the development of Lyme arthritis in individuals with the tick-borne illness, according to a paper published in the Journal of the American Academy of Orthopaedic Surgeons...


AP Top News at 3:35 p.m. EST

February 2, 2011 10:45 am | by The Associated Press | Comments

Mubarak backers attack foes with firebombs, bricksCAIRO (AP) — Thousands of supporters and opponents of President Hosni Mubarak battled in Cairo's main square Wednesday, raining stones, bottles and firebombs on each other in scenes of uncontrolled violence as soldiers stood by without intervening....

Brookdale Senior raises credit facility to $200M

February 2, 2011 9:45 am | by The Associated Press | Comments

Brookdale Senior Living Inc. said Wednesday it increased its credit facility to $200 million from $120 million and extended the maturity date until Jan. 31, 2016.The real estate investment trust plans to borrow $182 million under the facility to take advantage of market opportunities.GE Capital...


Thermo Fisher Scientific 4Q profit rises 9 percent

February 2, 2011 9:45 am | by The Associated Press | Comments

Scientific instrument maker Thermo Fisher Scientific Inc. said Wednesday its profit rose 9 percent in the fourth quarter as lower costs offset a drop in revenue.Thermo Fisher earned $297.5 million, or 75 cents per share, up from $273.3 million, or 65 cents per share, a year ago. Revenue fell 2...

Seattle Genetics offering $155 million in stock

February 2, 2011 9:45 am | by The Associated Press | Comments

Seattle Genetics Inc. said Wednesday it is publicly offering $155 million in common stock.The biotechnology company is offering 10 million shares at $15.50 apiece, marking a 4 percent discount to Tuesday's closing price of $16.17.Shares of Seattle Genetics fell 51 cents, or 3.2 percent, to...

PanCareSurFup: Major EU project to tackle complications of childhood cancer treatment

February 2, 2011 8:39 am | by EurekAlert | Comments

(Lund University) An increasing number of children survive cancer. However, many of them pay a high price. The harsh treatment can lead to hormone imbalances that affect sexual and physical development. Others are affected by infertility, cardiovascular or kidney problems or...


Early detection of lung cancer

February 2, 2011 8:39 am | by EurekAlert | Comments

(Fraunhofer-Gesellschaft) The earlier cancers can be detected, the better the chances of a cure. Researchers are now working to develop a new diagnostics platform with which the illness can be diagnosed in its early stages, even during a visit to the general practitioner: protein...


Sonoma Orthopedic Products® Announces Key License and Distribution Agreement for Japan

February 2, 2011 7:36 am | by Bio-Medicine.Org | Comments

SANTA ROSA, Calif., Feb. 2, 2011 /- Sonoma Orthopedic Products announced that it has entered into a licensing and distribution agreement with Ai-Medic, a subsidiary of Olympus® Business Creation Corporation.  Ai-Medic is a leading supplier of orthopedic products in the Japanese...


DRIVE4COPD Moves 1 Million People to Get Screened and Determine Personal COPD Risk in First Year

February 2, 2011 7:33 am | by Bio-Medicine.Org | Comments

RIDGEFIELD, Conn., Feb. 2, 2011 /- DRIVE4COPD today announced that it achieved its goal of screening 1 million Americans to determine their risk for chronic obstructive pulmonary disease (COPD) in its first year. The health awareness campaign aims to make a fundamental change in how COPD...


Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab

February 2, 2011 7:33 am | by Bio-Medicine.Org | Comments

INDIANAPOLIS and PRINCETON, N.J., Feb. 2, 2011 /- Eli Lilly and Company (NYSE: LLY ) and Bristol-Myers Squibb Company (NYSE: BMY ) announced today that they have stopped enrollment in one of their two global Phase III studies evaluating necitumumab, an investigational anti-cancer agent,...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.